Amylase enzymes

Patent metadata

Field	Value
Publication number	US-12351841-B2
Application number	US-201917057853-A
Country	US
Kind code	B2
Filing date	May 29, 2019
Priority date	May 29, 2018
Publication date	Jul 8, 2025
Grant date	Jul 8, 2025

Abstract

The present invention relates to variants of an alpha-amylase which have an increased exoamylase activity compared to the parent alpha-amylase. The present invention also relates to methods of making the variant alpha-amylase and the use of the variant alpha-amylase in baking, detergents, personal care products, in the processing of textiles, in pulp and paper processing, in the production of ethanol, lignocellulosic ethanol or syrups and as viscosity breaker in oilfield and mining industries.

First claim

What is claimed is:

1. A variant polypeptide of the alpha-amylase according to SEQ ID No. 1, comprising an amino acid sequence which is at least 90% identical to the sequence according to SEQ ID No. 1 and having alpha-amylase activity, wherein the variant polypeptide has an increased exoamylase activity compared to the alpha-amylase according to SEQ ID No. 1,
wherein the variant comprises at least one amino acid modification compared to the amino acid sequence according to SEQ ID No. 1 and
wherein the at least one amino acid modification is an amino acid substitution selected from the group consisting of: K2H, Y3R, S4T, P21E, P21W, G22Q, 125W, W26G, T29G, Q32R, P35K, 145M, G53A, S59P, F68P, K76R, R82N, E88Y, V90G, V90M, N91T, A96T, A105W, L117R, Y126V, W128Y, V134A, A141T, K152M, G160E, G160V, W175N, F197A, F197K, V200S, W234C, Y236H, F243A, F243K, F243T, D256A, N257R, T258C, P261C, P261F, V264R, G270Y, 1292A, I292E, V311L, N380L, G416Q, G423M, A433W, and V435S in the numbering of SEQ ID No. 1.

2. The variant polypeptide of claim 1 , wherein the variant polypeptide comprises a combination of amino acid modifications compared to the amino acid sequence according to SEQ ID No. 1.

3. The variant polypeptide of claim 2 , wherein the combination of amino acid modifications is a combination of amino acid substitutions which is selected from the group consisting of:
(a) G22Q, P35K, S59P, W128Y, D256A;
(b) G22Q, W128Y, W175N, V200S, A433W;
(c) G22Q, P35K, S59P, D256A;
(d) G22Q, W175N, V200S, D256A, A433W;
(e) W128Y, W175N, D256A;
(f) G22Q, S59P, V200S, D256A, A433W;
(g) G22Q, W175N, V200S, D256A;
(h) G22Q, S59P;
(i) G22Q, P35K, W128Y, W175N, V200S, D256A, A433W;
(j) G22Q, P35K, S59P, W128Y, A433W;
(k) G22Q, W128Y, W175N, D256A;
(l) P35K, W128Y, V200S, D256A;
(m) G22Q, S59P, W175N, V200S, A433W;
(n) G22Q, S59P, W128Y, V200S, A433W;
(o) G22Q, S59P, W175N, V200S, D256A, A433W;
(p) G22Q, S59P, W128Y, D256A;
(q) S59P, V200S, D256A, A433W;
(r) P35K, S59P, W128Y, W175N, V200S, D256A, A433W;
(s) G22Q, S59P, W128Y, D256A, A433W;
(t) G22Q, S59P, W128Y, W175N, V200S, 433W;
(u) G22Q, W128Y, W175N, A433W;
(v) S59P, W128Y, V200S;
(w) P35K, S59P, V200S, A433W;
(x) S59P, W128Y, V200S, D256A;
(y) S59P, W128Y, V200S, A433W; and
(z) W128Y, V200S, A433W
in the numbering of SEQ ID No. 1.

4. The variant polypeptide according to claim 1 , wherein the variant polypeptide is a fragment of the full length amino acid sequence according to SEQ ID No. 1.

5. A variant polypeptide comprising a hybrid of at least one variant polypeptide according to claim 1 , and a second polypeptide having amylase activity, wherein the hybrid has alpha-amylase activity.

6. A composition comprising the variant polypeptide according to claim 1 .

7. The composition according to claim 6 , further comprising a second enzyme.

8. The composition according to claim 7 , wherein the second enzyme is selected from the group consisting of: a second alpha-amylase, a lipase, a beta-amylase, a G4-amylase, a xylanase, a protease, a cellulase, a glucoamylase, an oxidoreductase, a phospholipase, and a cyclodextrin glucanotransferase.

9. A method of making a variant polypeptide comprising: providing a template nucleic acid sequence encoding the polypeptide variant according to claim 1 , transforming the template nucleic acid sequence into an expression host, cultivating the expression host to produce the variant polypeptide, and purifying the variant polypeptide.

10. The method of claim 9 , wherein the template nucleic acid is a variant nucleic acid sequence of the nucleic acid sequence as set forth in SEQ ID NO. 2, wherein the variant nucleic acid sequence is a nucleic acid sequence that is at least 90% identical to the nucleic acid sequence as set forth in SEQ ID No. 2, wherein the variant nucleic acid sequence encodes a polypeptide having alpha-amylase activity and having an increased exoamylase activity compared to the alpha-amylase encoded by the nucleic acid sequence according to SEQ ID No.2.

11. A method of preparing a dough or a baked product prepared from the dough, the method comprising adding a variant polypeptide according to claim 1 to the dough and eventually baking the dough.

12. The composition of claim 6 , wherein the composition is used for processing starch, for cleaning or washing textiles, hard surfaces, or dishes, for making ethanol, for treating an oil well, for processing pulp or paper, for feeding an animal or for making syrup.

Assignees

• Basf Se

Inventors

• Urbina Hugo
• Qureshi Asfia
• Huston Davenport Adrienne
• Tan Xuqiu
• Kutscher Jochen
• Funke Andreas
• Seitter Michael
• Haefner Stefan
• Le Anh-Huy Phan

Classifications

• C12N9/2411

  Amylases · CPC title

• C11D3/38636

  containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase · CPC title

• C12Y302/01001 Primary

  Alpha-amylase (3.2.1.1) · CPC title

• C12N9/2417

  from microbiological source · CPC title

• A21D8/042

  with enzymes · CPC title